Abel Hall LLC’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Abel Hall LLC's BMY Position: Q3 2026 in Review
Abel Hall LLC reduced its Bristol-Myers Squibb (BMY) stake by 33% in Q3 2026, selling an estimated $437K and leaving 13,852 shares worth $864K. The position accounts for 0.16% of the portfolio, ranked #91.
Abel Hall LLC first reported a position in BMY in Q4 2023 and has held it in 12 quarters since. The position peaked at $1.28M in Q1 2026. 907 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Abel Hall LLC held 13,852 shares of Bristol-Myers Squibb worth $864K as of Q3 2026.
- Abel Hall LLC sold 6,915 Bristol-Myers Squibb shares in Q3 2026, an estimated $437K.
- Bristol-Myers Squibb made up 0.16% of Abel Hall LLC's portfolio in Q3 2026, its #91 holding.
- Abel Hall LLC first reported a position in Bristol-Myers Squibb in Q4 2023 and has held it in 12 quarters since.
- Abel Hall LLC's Bristol-Myers Squibb position peaked at $1.28M in Q1 2026.
- 907 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Abel Hall LLC's 13F filing for Q3 2026, filed 19 Oct 2026.